Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.9B | 11.6B | 11.8B | 11.1B |
Cost of revenue | 8.4B | 8.2B | 8.4B | 8.2B |
Gross profit | 3.6B | 3.3B | 3.4B | 2.9B |
Operating expense | ||||
Research & development | 520.6M | 583.3M | 511.1M | 501.6M |
Selling general and admin | 838.2M | 805.3M | 686.4M | 653.0M |
Other operating expenses | — | — | — | — |
Operating income | 2.2B | 1.9B | 2.2B | 1.7B |
Non operating interest income | ||||
Income | 558.6M | 552.5M | 529.9M | 489.4M |
Expense | 85.2M | 88.2M | 98.6M | 85.6M |
Other income expense | — | — | — | — |
Pretax income | 2.7B | 2.3B | 2.7B | 2.1B |
Tax provision | 268.7M | 489.2M | 545.8M | 347.6M |
Net income | 2.4B | 1.8B | 2.1B | 1.8B |
Basic EPS | 1.3 | — | 1.3 | 1.1 |
Diluted EPS | 1.3 | — | 1.3 | 1.1 |
Basic average shares | 1.8B | — | 1.7B | 1.7B |
Diluted average shares | 1.9B | — | 1.7B | 1.7B |
EBITDA | 4.9B | 4.7B | 4.8B | 4.4B |
Net income from continuing op. | 2.7B | 2.3B | 2.7B | 2.1B |
Minority interests | 7.8M | 2.9M | -3.7M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |